SLG
GILD icon

Stanley-Laman Group’s Gilead Sciences GILD Stock Holding History

Stanley-Laman Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,554
Closed -$212K – 237
2023
Q1 		$212K Buy
+2,554
New +$212K 0.04% 217
2020
Q4 		– Sell
-3,217
Closed -$203K – 247
2020
Q3 		$203K Sell
3,217
-120
-4% -$8.32K 0.04% 218
2020
Q2 		$257K Sell
3,337
-1,983
-37% -$152K 0.06% 223
2020
Q1 		$398K Sell
5,320
-19,506
-79% -$1.35M 0.12% 193
2019
Q4 		$1.61M Sell
24,826
-2,052
-8% -$134K 0.38% 73
2019
Q3 		$1.7M Buy
26,878
+22
+0.1% +$1.44K 0.42% 70
2019
Q2 		$1.81M Sell
26,856
-4,285
-14% -$282K 0.44% 62
2019
Q1 		$2.02M Buy
31,141
+4,378
+16% +$291K 0.49% 59
2018
Q4 		$1.67M Sell
26,763
-2,670
-9% -$187K 0.46% 63
2018
Q3 		$2.27M Sell
29,433
-297
-1% -$22.4K 0.56% 51
2018
Q2 		$2.11M Sell
29,730
-2,538
-8% -$179K 0.47% 60
2018
Q1 		$2.43M Sell
32,268
-2,633
-8% -$209K 0.55% 50
2017
Q4 		$2.5M Buy
34,901
+162
+0.5% +$12.3K 0.54% 58
2017
Q3 		$2.81M Sell
34,739
-5,051
-13% -$386K 0.75% 44
2017
Q2 		$2.82M Buy
+39,790
New +$2.65M 0.76% 42
2016
Q4 		– Sell
-128,022
Closed -$10.1M – 275
2016
Q3 		$10.1M Buy
128,022
+125,569
+5,119% +$10.2M 4.15% 3
2016
Q2 		$205K Buy
+2,453
New +$218K 0.08% 225
2016
Q1 		– Sell
-8,552
Closed -$865K – 316
2015
Q4 		$865K Buy
8,552
+6,019
+238% +$626K 0.15% 161
2015
Q3 		$249K Buy
2,533
+500
+25% +$55.5K 0.05% 268
2015
Q2 		$238K Sell
2,033
-300
-13% -$32.8K 0.04% 265
2015
Q1 		$229K Buy
+2,333
New +$237K 0.04% 280

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stanley-Laman Group's GILD Position: Q2 2023 in Review

Stanley-Laman Group sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 2,554 shares — an estimated $212K sold.

Stanley-Laman Group first reported a position in GILD in Q1 2015 and held it in 21 quarters. The position peaked at $10.1M in Q3 2016. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Stanley-Laman Group reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Stanley-Laman Group sold 2,554 Gilead Sciences shares in Q2 2023, an estimated $212K.
  • Stanley-Laman Group first reported a position in Gilead Sciences in Q1 2015 and held it in 21 quarters.
  • Stanley-Laman Group's Gilead Sciences position peaked at $10.1M in Q3 2016.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Stanley-Laman Group's 13F filing for Q2 2023, filed 8 Aug 2023.